<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Bone and soft tissue sarcomas, tumors of the skin</journal-id><journal-title-group><journal-title xml:lang="en">Bone and soft tissue sarcomas, tumors of the skin</journal-title><trans-title-group xml:lang="ru"><trans-title>Саркомы костей, мягких тканей и опухоли кожи</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2219-4614</issn><issn publication-format="electronic">2782-3687</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">746</article-id><article-id pub-id-type="doi">10.17650/2219-4614-2025-17-2-47-59</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>BONE SARCOMAS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>САРКОМЫ КОСТЕЙ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Surgical treatment of patients with pelvic bone metastases</article-title><trans-title-group xml:lang="ru"><trans-title>Хирургическое лечение больных с метастазами в костях таза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9557-3685</contrib-id><name-alternatives><name xml:lang="en"><surname>Sofronov</surname><given-names>D. I.</given-names></name><name xml:lang="ru"><surname>Софронов</surname><given-names>Д. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115522</p></bio><bio xml:lang="ru"><p>115522 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3672-1742</contrib-id><name-alternatives><name xml:lang="en"><surname>Sushentsov</surname><given-names>E. A.</given-names></name><name xml:lang="ru"><surname>Сушенцов</surname><given-names>Е. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Evgeny Alexandrovich Sushentsov</p><p>24 Kashirskoe Shosse, Moscow 115522</p></bio><bio xml:lang="ru"><p>Евгений Александрович Сушенцов</p><p>115522 Москва, Каширское шоссе, 24</p></bio><email>crcspine@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6239-8152</contrib-id><name-alternatives><name xml:lang="en"><surname>Agaev</surname><given-names>D. K.</given-names></name><name xml:lang="ru"><surname>Агаев</surname><given-names>Д. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115522</p></bio><bio xml:lang="ru"><p>115522 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3512-0390</contrib-id><name-alternatives><name xml:lang="en"><surname>Borzov</surname><given-names>K. A.</given-names></name><name xml:lang="ru"><surname>Борзов</surname><given-names>К. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115522</p></bio><bio xml:lang="ru"><p>115522 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-4043-7698</contrib-id><name-alternatives><name xml:lang="en"><surname>Dzhamukhanova</surname><given-names>Ya. A.</given-names></name><name xml:lang="ru"><surname>Джамуханова</surname><given-names>Я. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115522</p></bio><bio xml:lang="ru"><p>115522 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-7747-7314</contrib-id><name-alternatives><name xml:lang="en"><surname>Popova</surname><given-names>V. E.</given-names></name><name xml:lang="ru"><surname>Попова</surname><given-names>В. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115522</p></bio><bio xml:lang="ru"><p>115522 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Adzhieva</surname><given-names>M. D.</given-names></name><name xml:lang="ru"><surname>Аджиева</surname><given-names>М. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Ostrovityanova St., Moscow 117513</p></bio><bio xml:lang="ru"><p>117513 Москва, ул. Островитянова, 1</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4516-3255</contrib-id><name-alternatives><name xml:lang="en"><surname>Fedorova</surname><given-names>V. B.</given-names></name><name xml:lang="ru"><surname>Федорова</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115522</p></bio><bio xml:lang="ru"><p>115522 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7748-9527</contrib-id><name-alternatives><name xml:lang="en"><surname>Matveev</surname><given-names>V. B.</given-names></name><name xml:lang="ru"><surname>Матвеев</surname><given-names>В. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115522</p></bio><bio xml:lang="ru"><p>115522 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2038-3729</contrib-id><name-alternatives><name xml:lang="en"><surname>Valiev</surname><given-names>A. K.</given-names></name><name xml:lang="ru"><surname>Валиев</surname><given-names>А. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115522</p></bio><bio xml:lang="ru"><p>115522 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3396-4047</contrib-id><name-alternatives><name xml:lang="en"><surname>Beishembaev</surname><given-names>M. I.</given-names></name><name xml:lang="ru"><surname>Бейшембаев</surname><given-names>М. И.</given-names></name></name-alternatives><address><country country="KG">Kyrgyzstan</country></address><bio xml:lang="en"><p>Bld. 8, 92 Isa Akhunbaeva St., Bishkek 720064</p></bio><bio xml:lang="ru"><p>720064 Бишкек, ул. Исы Ахунбаева, 92, корп. 8</p></bio><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">National Center of Oncology and Hematology, Ministry of Health of Kyrgyz Republiс</institution></aff><aff><institution xml:lang="ru">Национальный центр онкологии и гематологии Минздрава Кыргызской Республики</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-07-25" publication-format="electronic"><day>25</day><month>07</month><year>2025</year></pub-date><volume>17</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>47</fpage><lpage>59</lpage><history><date date-type="received" iso-8601-date="2025-07-24"><day>24</day><month>07</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-07-24"><day>24</day><month>07</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Sofronov D.I., Sushentsov E.A., Agaev D.K., Borzov K.A., Dzhamukhanova Y.A., Popova V.E., Adzhieva M.D., Fedorova V.B., Matveev V.B., Valiev A.K., Beishembaev M.I.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Софронов Д.И., Сушенцов Е.А., Агаев Д.К., Борзов К.А., Джамуханова Я.А., Попова В.Е., Аджиева М.Д., Федорова А.В., Матвеев В.Б., Валиев А.К., Бейшембаев М.И.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Sofronov D.I., Sushentsov E.A., Agaev D.K., Borzov K.A., Dzhamukhanova Y.A., Popova V.E., Adzhieva M.D., Fedorova V.B., Matveev V.B., Valiev A.K., Beishembaev M.I.</copyright-holder><copyright-holder xml:lang="ru">Софронов Д.И., Сушенцов Е.А., Агаев Д.К., Борзов К.А., Джамуханова Я.А., Попова В.Е., Аджиева М.Д., Федорова А.В., Матвеев В.Б., Валиев А.К., Бейшембаев М.И.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://sarbon.abvpress.ru/jour/article/view/746">https://sarbon.abvpress.ru/jour/article/view/746</self-uri><abstract xml:lang="en"><p><bold>Introduction</bold>. Pelvic bone metastases are a common complication of malignant tumors, leading to pain, pathological fractures, and decreased quality of life. Surgical treatment plays a key role in palliative care, but the optimal approaches remain controversial.<bold>Aim</bold>. To evaluate the results of surgical treatment of patients with pelvic bone metastases, including oncologic and functional outcomes, as well as complication rates.<bold>Materials and methods</bold>. A retrospective analysis of 39 patients (21 men, 18 women; median age 55 years) who underwent surgical treatment for metastatic pelvic bone lesions in the period 2002–2022 was performed. The most common localizations were the ilium (10 (25.6 %) cases) and sacrum (13 (33.3 %) cases). A solitary lesion was detected in 33 (84.6 %) patients and multiple bone lesions in 6 (5.4 %) patients. The primary lesion in most cases (in 19 (48.7 %) patients) was kidney cancer. Radical (wide resections) (71.8 % cases) and palliative (decompression and excohleations) (23.1 % cases) methods were used. Survival, complications (according to the Clavien–Dindo classification), pain dynamics (according to the visual analog and Watkins scales) and functional status (according to the Karnofsky scale) were assessed.<bold>Results</bold>. Complications developed in 28.2 % of patients, mainly after resections involving the acetabulum (p = 0.029). The leading complications were deep infections (8 cases), superficial necrosis (3 cases), which required additional surgical interventions. The median overall survival was 45 months, with solitary metastases – 93 months, with multiple metastases – 20 months (p = 0.019). Intralesional resections were associated with worse survival (p = 0.028). A significant decrease in pain (from 5 to 2 according to the visual analog scale; p &lt;0.001) and improvement in functional status (according to the Karnofsky scale; p = 0.022) were noted. <bold>Conclusion</bold>. Radical resections provide better survival in solitary metastases group, while palliative methods are appropriate for multiple lesions. The choice of tactics requires a multidisciplinary approach, taking into account the prognosis and extent of the lesion.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение</bold>. Метастазы в костях таза являются частым осложнением злокачественных опухолей и приводят к развитию болевого синдрома, патологических переломов и снижению качества жизни пациентов. Хирургическое лечение играет ключевую роль в паллиативной помощи при данной патологии, но оптимальные подходы к терапии остаются предметом дискуссий.<bold>Цель исследования</bold> – оценить результаты хирургического лечения пациентов с метастазами в костях таза, включая онкологические и функциональные исходы, а также частоту развития осложнений.<bold>Материалы и методы</bold>. Проведен ретроспективный анализ данных 39 пациентов (21 мужчина, 18 женщин; медиана возраста – 55 лет), которым в период 2002–2022 гг. проведено хирургическое лечение по поводу метастатического поражения костей таза. Чаще всего метастазы локализовались в подвздошной кости (10 (25,6 %) случаев) и крестце (13 (33,3 %) случаев). У 33 (84,6 %) пациентов выявлен солитарный очаг, у 6 (5,4 %) – множественное поражение костей. Первичным очагом в большинстве случаев (у 19 (48,7 %) больных) был рак почки. Использовались радикальные (широкие) резекции (71,8 % случаев) и паллиативные методы (декомпрессии и экскохлеации) (23,1 % случаев). Оценивались выживаемость, осложнения (по классификации Clavien–Dindo), динамика боли (по визуальной аналоговой шкале и шкале Watkins) и функциональный статус (по шкале Карновского).<bold>Результаты</bold>. Осложнения развились у 28,2 % пациентов, чаще после резекций с вовлечением вертлужной впадины (p = 0,029). Основными нежелательными явлениями были глубокие инфекции (8 случаев) и поверхностные некрозы (3 случая), которые потребовали проведения дополнительных хирургических вмешательств. Медиана общей выживаемости пациентов составила 45 мес, при солитарных метастазах – 93 мес, при множественных – 20 мес (p = 0,019). Внутриочаговые резекции ассоциировались с худшей выживаемостью (p = 0,028). Отмечены значительное снижение интенсивности боли (с 5 до 2 баллов по визуальной аналоговой шкале; p &lt;0,001) и улучшение функционального статуса по шкале Карновского (p = 0,022).<bold>Заключение</bold>. Радикальные резекции обеспечивают лучшие показатели выживаемости при солитарных метастазах, тогда как паллиативные методы целесообразно применять при множественных метастазах. Выбор тактики лечения требует мультидисциплинарного подхода с учетом прогноза и объема метастатического поражения.</p></trans-abstract><kwd-group xml:lang="en"><kwd>pelvic bones</kwd><kwd>bone metastasis</kwd><kwd>surgical treatment</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>кости таза</kwd><kwd>метастаз в костях</kwd><kwd>хирургическое лечение</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Aboulafia A.J., Levine A.M., Schmidt D., Aboulafia D. Surgical therapy of bone metastases. Semin Oncol 2007;34(3):206–14. DOI: 10.1053/j.seminoncol.2007.03.002</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Picci P., Manfrini M., Fabbri N. et al. Atlas of musculoskeletal tumors and tumorlike lesions. Berlin, Germany, Springer, 2014. 728 p. 3. Starčević D., G. Simić, Đuričić et al. Kliničko-patološke karakteristike tumora kostiju karlice. Medicinski Podmladak 2021;72(4):20–6. (In Polish). DOI: https://doi.org/10.5937/mp72-33519</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Hage W.D., Aboulafia A.J., Aboulafia D.M. Incidence, location, and diagnostic evaluation of metastatic bone disease. Orthop Clin North Am 2000;31(4):515–28. DOI: 10.1016/s0030-5898(05)70171-1</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Gutowski C.J., Zmistowski B., Fabbri N. et al. Should the use of biologic agents in patients with renal and lung cancer affect our surgical management of femoral metastases? Clin Orthop Relat Res 2019;477(4):707–14. DOI: 10.1097/CORR.000000000000043</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Motzer R.J., Haas N.B., Donskov F. et al. Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma. J Clin Oncol 2017;35(35):3916–23. DOI: 10.1200/JCO.2017.73.5324</mixed-citation></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Usmanova E.B., Shchelkova O.Yu., Sushentsov E.A. et al. Quality of life and survival rate in patients with bone tumors. Sarkomy kostei, miagkikh tkanei i opukholi kozhi = Bone and Soft Tissue Sarcomas, Tumors of the Skin 2019;11(2):34–9. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Усманова Е.Б., Щелкова О.Ю., Сушенцов Е.А. и др. Качество жизни и выживаемость пациентов с опухолевым поражением костей. Саркомы костей, мягких тканей и опухоли кожи 2019;11(2):34–9.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><mixed-citation>Li S., Peng Y., Weinhandl E.D. et al. Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin Epidemiol 2012;4(1):87–93. DOI: 10.2147/CLEP.S28339</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Morrogh M., Miner T.J., Park A. et al. A prospective evaluation of the durability of palliative interventions for patients with metastatic breast cancer. Cancer 2010;116(14):3338–47. DOI: 10.1002/cncr.25034</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Müller D.A., Capanna R. The surgical treatment of pelvic bone metastases. Adv Orthop 2015;2015(01):525–63. DOI: 10.1155/2015/525363</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Ji T., Guo W., Yang R.L. et al. Clinical outcome and quality of life after surgery for peri-acetabular metastases. J Bone Joint Surg Br 2011;93(8):1104–10. DOI: 10.1302/0301-620X.93B8.26155</mixed-citation></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Bukharov A.V., Kurilchik A.A., Barashev A.A. et al. Artificial intelligence in personalized selection of surgical treatment tactics for bone metastases. Sarkomy kostei, miagkikh tkanei i opukholi kozhi = Bone and Soft Tissue Sarcomas, Tumors of the Skin 2024;16(3):11–18. (In Russ.). DOI: 10.17650/2219-4614-2024-16-3-11-18</mixed-citation><mixed-citation xml:lang="ru">Бухаров А.B., Курильчик А.А., Барашев А.А. и др. Искусственный интеллект в персонализированном выборе тактики хирургического лечения при метастатическом поражении костей. Саркомы костей, мягких тканей и опухоли кожи 2024;16(3):11–8. DOI: 10.17650/2219-4614-2024-16-3-11-18</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Aliev М.D., Stepanova A.M., Musaev E.R. et al. Spinal metastases in breast cancer patients. Prognostic factors. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2015;1(3):61–7. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Алиев М.Д., Степанова А.М., Мусаев Э.Р. и др. Метастатическое поражение позвоночника у больных раком молочной железы. Факторы Прогноза. Сибирский онкологический журнал 2015;1(3):61–7.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Tikhilov R.M., Ptashnikov D.A., Grigoriev P.V. et al. Results of minimally invasive surgical treatment of patients with the threat of pathological fracture against the background of metastatic lesions of the proximal femur. Travmatologiya i ortopediya Rossii = Traumatology and Orthopedics of Russia 2016;22(3):54–64. (In Russ.). DOI: 10.21823/2311-2905-2016-22-3-54-64</mixed-citation><mixed-citation xml:lang="ru">Тихилов Р.М., Пташников Д.А., Григорьев П.В. и др. Результаты малоинвазивного хирургического лечения пациентов с угрозой патологического перелома на фоне метастатического поражения проксимального отдела бедренной кости. Травматология и ортопедия России 2016;22(3):54–64. DOI: 10.21823/2311-2905-2016-22-3-54-64</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Fedyanin M.Yu., Gladkov O.A., Gordeev S.S. et al. Metastatic colon cancer: updating clinical guidelines in 2024. Khirurgiya i onkologiya = Surgery and Oncology 2024;14(4):31–42. (In Russ.). DOI: 10.17650/2949-5857-2024-14-4-31-42</mixed-citation><mixed-citation xml:lang="ru">Федянин М.Ю., Гладков О. А., Гордеев С. С. и др. Метастатичес- кий рак толстой кишки: обновление клинических рекомендаций в 2024 г. Хирургия и онкология 2024;14(4):31–42. DOI: 10.17650/2949-5857-2024-14-4-31-42</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><mixed-citation>Quinn R. Metastatic disease to the hip and pelvis: surgical management. Techniq Orthop 2007;22(2):78–87. DOI: 10.1097/BTO.0b013e31812233a2</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Surgery of Pelvic Bone Tumors. Ed. by Ruggieri P., Angelini A. Springer, 2021. Pp. 165–183.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Kim W., Han I., Kang S. et al. Non-spine bone metastasis as an initial manifestation of cancer in Korea. J Korean Med Sci 2014;29(3):357–62. DOI: 10.3346/jkms.2014.29.3.357</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Denaro V., Di Martino A., Piccioli A., Ortiz-Cruz E. Metastases to the pelvis. Management of bone metastases: a multidisciplinary guide. 2019. Pp. 159–165.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Capanna R., Campanacci D.A. The treatment of metastases in the appendicular skeleton. J Bone Joint Surg Br 2001;83(4):471–81. DOI: 10.1302/0301-620x.83b4.12202</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Charles T., Ameye L., Gebhart M. Surgical treatment for periacetabular metastatic lesions. Eur J Surg Oncol 2017;43(9):1727–32. DOI: 10.1016/j.ejso.2017.03.018</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Tillman R., Tsuda Y., Puthiya Veettil M. et al. The long-term outcomes of modified Harrington procedure using antegrade pins for periacetabular metastasis and haematological diseases. Bone Joint J 2019;101-B(12): 1557–62. DOI: 10.1302/0301-620X.101B12.BJJ-2019-0265.R1</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Yasko A.W., Rutledge J., Lewis V.O. et al. Disease- and recurrence-free survival after surgical resection of solitary bone metastases of the pelvis. Clin Orthop Relat Res 2007;459:128–32. DOI: 10.1097/BLO.0b013e3180619533</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Langerhuizen D.W., Janssen S.J., Van Der Vliet Q.M. et al. Metastasectomy, intralesional resection, or stabilization only in the treatment of bone metastases from renal cell carcinoma. J Surg Oncol 2016;114(12):237–45. DOI: 10.1002/jso.24284</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Krishnan C.K., Han I., Kim H.S. Outcome after surgery for metastases to the pelvic bone: a single institutional experience. Clin Orthop Surg 2017;9(1):116–25. DOI: 10.4055/cios.2017.9.1.116</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Ruggieri P., Mavrogenis A.F., Angelini A. et al. Metastases of the pelvis: does resection improve survival? Orthopedics 2011;34(7):e236–44. DOI: 10.3928/01477447-20110526-07</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Hansen B.H., Keller J.Ø. Surgical treatment of skeletal metastases in the pelvis and extremities. Ugeskr Laeger 2005;167(48):4559–62.</mixed-citation></ref></ref-list></back></article>
